slotkoers
Shenzhen S.E.
00:00:00 16-07-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
5,03
CNY
|
-1,57%
|
|
-0,20%
|
-30,04%
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
7.317
|
11.525
|
13.759
|
13.338
|
11.347
|
11.639
|
Bedrijfswaarde
1 |
5.811
|
10.169
|
12.220
|
12.094
|
10.858
|
11.273
|
K/w-verhouding
|
11,9
x
|
14,8
x
|
42,5
x
|
137
x
|
140
x
|
-27,7
x
|
Dividendrendement
|
6,38%
|
4,21%
|
0,24%
|
1,21%
|
0,71%
|
-
|
Marktkapitalisatie/omzet
|
2,69
x
|
3,92
x
|
5,57
x
|
5,37
x
|
4,2
x
|
5,36
x
|
Bedrijfswaarde/omzet
|
2,14
x
|
3,46
x
|
4,94
x
|
4,87
x
|
4,02
x
|
5,19
x
|
Bedrijfswaarde/EBITDA
|
6,79
x
|
9,47
x
|
18
x
|
29,8
x
|
25,9
x
|
122
x
|
Bedrijfswaarde/FCF
|
15
x
|
16,5
x
|
16,9
x
|
30,1
x
|
152
x
|
55,6
x
|
FCF Yield
|
6,69%
|
6,06%
|
5,92%
|
3,32%
|
0,66%
|
1,8%
|
Price to Book
|
1,36
x
|
2,01
x
|
2,35
x
|
2,18
x
|
1,86
x
|
2,08
x
|
Aantal aandelen (in duizenden)
|
1.618.820
|
1.618.715
|
1.618.715
|
1.618.715
|
1.618.715
|
1.618.715
|
Referentieprijs
2 |
4,520
|
7,120
|
8,500
|
8,240
|
7,010
|
7,190
|
Datum van publicatie
|
17-02-19
|
22-01-20
|
28-04-21
|
22-04-22
|
24-04-23
|
28-04-24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
2.719
|
2.941
|
2.471
|
2.485
|
2.704
|
2.172
|
EBITDA
1 |
855,5
|
1.074
|
678,6
|
406,2
|
420
|
92,48
|
Bedrijfsresultaat (EBIT)
1 |
663,3
|
870,8
|
422,1
|
117,2
|
88,57
|
-267,5
|
Operationele Marge
|
24,4%
|
29,6%
|
17,08%
|
4,72%
|
3,28%
|
-12,32%
|
Resultaat voor belastingen (EBT)
1 |
697,3
|
912,5
|
393,5
|
123
|
100,8
|
-466,2
|
Nettowinst (verlies)
1 |
605
|
770,8
|
319,7
|
95,23
|
88,01
|
-420,1
|
Nettomarge
|
22,25%
|
26,2%
|
12,94%
|
3,83%
|
3,25%
|
-19,34%
|
WPA
2 |
0,3800
|
0,4800
|
0,2000
|
0,0600
|
0,0500
|
-0,2600
|
Free Cash Flow
1 |
388,7
|
616,7
|
723,9
|
401,5
|
71,41
|
202,8
|
FCF-marge
|
14,3%
|
20,97%
|
29,29%
|
16,16%
|
2,64%
|
9,34%
|
Kasstroomconversie (ebitda)
|
45,43%
|
57,43%
|
106,68%
|
98,82%
|
17%
|
219,27%
|
Kasstroomconversie (nettowinst)
|
64,24%
|
80,01%
|
226,41%
|
421,58%
|
81,13%
|
-
|
Dividend per aandeel
2 |
0,2883
|
0,3000
|
0,0200
|
0,1000
|
0,0500
|
-
|
Datum van publicatie
|
17-02-19
|
22-01-20
|
28-04-21
|
22-04-22
|
24-04-23
|
28-04-24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
1 |
1.506
|
1.356
|
1.539
|
1.244
|
489
|
366
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
389
|
617
|
724
|
401
|
71,4
|
203
|
ROE (netto-inkomsten/eigen vermogen)
|
11,5%
|
13,9%
|
5,52%
|
1,57%
|
1,41%
|
-7,2%
|
ROA (netto-inkomsten/totale activa)
|
5,72%
|
7,9%
|
3,79%
|
0,96%
|
0,67%
|
-2,1%
|
Totale activa
1 |
10.582
|
9.760
|
8.439
|
9.882
|
13.049
|
19.993
|
Nettoactief per aandeel
2 |
3,330
|
3,540
|
3,620
|
3,780
|
3,770
|
3,460
|
Cashflow per aandeel
2 |
1,210
|
0,9600
|
1,220
|
1,130
|
0,9200
|
0,8800
|
Capex
1 |
256
|
161
|
74,2
|
230
|
179
|
153
|
Capex/omzet
|
9,41%
|
5,46%
|
3%
|
9,24%
|
6,64%
|
7,05%
|
Datum van publicatie
|
17-02-19
|
22-01-20
|
28-04-21
|
22-04-22
|
24-04-23
|
28-04-24
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| -30,04% | 1,12 mld. | | +61,53% | 856 mld. | | +38,95% | 631 mld. | | -3,66% | 359 mld. | | +15,06% | 325 mld. | | +9,18% | 297 mld. | | +5,89% | 234 mld. | | +16,53% | 226 mld. | | +15,67% | 177 mld. | | +2,47% | 165 mld. |
Farmaceutische producten - Andere
|